RIKEN Headquarters Homepage

RIKEN and NUH launched a feasibility study

May 8, 2007 Press Conference in Singapore: RIKEN’s Genome Exploration Research Group of Genome Science Centre (GSC) (currently Omics Science Center), Director Dr. Yoshihide HAYASHIZAKI, in collaboration with National University of Singapore (NUS) and National University Hospital,Singapore (NUH) has launched a feasibility study on the clinical application of SMAP for point-of-care diagnosis of drug efficacy.